Search
-
Ipsos Healthcare Launches ‘NASH’ Therapy Monitor
Ipsos Healthcare has launched its Nonalcoholic Steatohepatitis (NASH) Therapy Monitor in the US and EU5 initially – France, Germany, Italy, Spain, and UK – with other markets available on demand.
-
Is the Behavioural Lens Out of Focus?
How to make behaviour work in CPG, financial services, technology and retail? Using behavioural science to get closer to the consumer.
-
International Survey on Connected Health: Coming Ready or Not!
Connected Health – sometimes referred to as Digital Health – is a potential game-changer for global healthcare.
-
Brexit and the UK Pharma Industry
The ‘In’ and ‘Out’ campaigns are now intensifying, but ‘Brexit’ has been a constant topic of conversation since the referendum date was announced 3 months ago. A British exit could have widespread repercussions for many sectors within the UK economy, especially in highly regulated and controlled industries such as pharmaceuticals.
-
Ipsos Healthcare Launches SyndicatedPD-L1Testing Monitor in Oncology
Ipsos Healthcare – the global healthcare division of Ipsos – has launched the syndicated PD-L1 Testing Monitor, a timely addition to the Ipsos Oncology Molecular Diagnostics Portfolio.
-
Taking Responsibility - Kythe Foundation in the Philippines
Today, the focus is on the Kythe Foundation in the Philippines.
-
Who Will Win the Race to Treat NASH?
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.
-
Pneumonia: A View From Europe
This study looks at awareness and perceptions of Pneumonia among the 50+ population in nine European markets.
-
How Concerned Are You About the Zika Virus?
In light of the most recent news regarding the spread of the Zika virus, Ipsos conducted a poll to gauge the level of concern about the virus among citizens of 27 countries around the world.
-
Harnessing Complexity: Companion Diagnostics in Oncology
As an increasing number of drugs gain approval for patients whose cancers have certain molecular characteristics, the promise of truly personalised medicine is edging closer towards reality.